Adhesive patch biotech Zosano Pharma files for a $65 million IPO

By
A A A

Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, filed on Tuesday with the SEC to raise up to $65 million in an initial public offering. The Fremont, CA-based company, which was spun out of Johnson & Johnson ( JNJ ) in 2006, plans to list on the NASDAQ under the symbol ZSAN. Zosano Pharma initially filed confidentially on May 13, 2014. Wedbush PacGrow, Ladenburg Thalmann and Roth Capital are the joint bookrunners on the deal. No pricing terms were disclosed.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: News Headlines , IPOs

Referenced Stocks: JNJ

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

What to Wear to a Wedding
What to Wear to a Wedding           
4th of July Outfits
4th of July Outfits                 

Stocks

Referenced

80%

Most Active by Volume

62,287,287
  • $17.03 ▼ 1.10%
26,194,993
  • $30.555 ▲ 1.24%
26,150,957
  • $126.44 ▼ 0.13%
25,197,634
  • $40.59 ▼ 6.26%
25,192,083
  • $19.07 ▲ 1.54%
24,563,617
  • $26.78 ▲ 0.45%
24,474,256
  • $5.85 ▲ 1.56%
24,111,132
  • $8.83 ▲ 2.08%
As of 7/2/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com